KIR⁺CD8⁺ T Cells Suppress Pathogenic T Cells and Are Active in Autoimmune Diseases and COVID-19

CD8+ T expressing inhibitory killer cell immunoglobulin-like receptors cells efficiently eliminated pathogenic gliadin-specific CD4+ T cells from celiac disease patients’ leukocytes in vitro.